SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Aventus

Aventus ($AVT.X) is trending as community members discuss its potential, citing its low market cap, limited supply, and partnerships with Vodafone and Polkadot. Some investors believe $AVT.X could see significant gains, drawing comparisons to other low-cap coins and pointing to its potential for a breakout. Recent partnerships, including with the Truth Network, and its technology are also being highlighted as potential catalysts.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending as the first U.S. spot ETF is expected to launch this week, giving it regulatory clarity and potential institutional access. The community is discussing the possible price action following the rate cut decision and anticipating a potential supply shock. Talk centers around long-term potential and the impact on global settlements.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy is trending as the stock price is not moving in sync with Bitcoin, leading to frustration among investors. The community is actively discussing whether the company's strategy of accumulating Bitcoin through debt is sustainable, especially with concerns about dilution and the stock's potential decoupling from Bitcoin's price movements. Some are speculating about potential catalysts like rate cuts or insider buying that could trigger a breakout.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

GRRR is trending due to a newly announced $1.4 billion contract to build AI-powered data centers, sparking bullish sentiment and discussions about potential revenue impact. While some community members express excitement and anticipate a significant price increase, others are scrutinizing the details of the deal and the legitimacy of the partner company. The contract news is also fueling speculation about a potential short squeeze, compounded by upcoming events that could further boost the stock.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending amidst market reactions to a recent Fed rate cut and commentary, with some traders expressing concerns about the Fed's future guidance and potential economic impacts. The community is actively discussing technical levels, potential market direction, and the influence of both economic data and political events on the ETF. Additionally, there is debate around Jimmy Kimmel's show being pulled and its implications for free speech.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending amid a mix of reactions to the Fed's rate cut decision and Powell's comments, with community members debating whether the market's direction reflects genuine economic optimism or a disconnect from reality. Concerns about inflation, job market uncertainties, and the potential impact of tariffs are being weighed against the backdrop of the index's strong YTD performance. Discussions also include political commentary, potential market manipulation, and individual stock picks within the broader index.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co.

$DIS is trending amid mixed reactions to recent news, including a deal with the NFL and earnings reports; the community is debating the implications of these developments, with some expressing concerns and disappointment, while others highlight the company's streaming growth and long-term potential. The stock's performance is also generating discussions around its valuation and future direction.

"What's Updog?" is a Community Led token.

UpDog

UpDog ($UPDOG.X) is trending as the community rallies around the meme-based token on the Solana network, drawing comparisons to other dog-themed coins. Discussions revolve around its potential for growth, its listing on Jupiter Exchange, and the meaning of "UpDog" itself. The community emphasizes the coin's longevity, locked liquidity, and its status as a 'joke meta pioneer.'

Bullish engages in the management of a digital asset platform. It also offers market infrastructure and information services. The company was founded by Brendan Francis Blumer in 2020 and is headquartered in George Town, Cayman Islands.

Bullish

Bullish (BLSH) is trending due to its recent earnings report and securing a BitLicense from New York, paving the way for its U.S. launch, with the community actively analyzing the implications of the license and earnings figures. Community members are discussing institutional interest, potential price targets, and the impact of these developments on future growth. Some traders express skepticism and frustration, while others remain optimistic about the company's long-term potential in the crypto space.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash is trending as community members highlight recent price movement and discuss potential targets. Some users point to its faster transaction times and lower fees compared to Bitcoin, speculating on its potential to outperform. Others note the limited supply and potential for significant growth as market focus shifts from speculation to utility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Analysts Believe Ascendis Pharma (ASND) Could Rally 29.83%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 29.8% in Ascendis Pharma (ASND). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

U.S.-listed shares of Ascendis Pharma climbed more than 7% in Thursday’s premarket session, setting the stage for their best open since early January.Late on Wednesday, the company reported better-than-expected fourth-quarter results and announced a share repurchase program.The Danish biopharma company posted Q4 revenue of €173.92 million ($180.6 million), up from €137.7 million a year ago, while its loss per share narrowed to €0.64 from €1.53.&nbsp;CEO Jan Mikkelsen said the company is “positioned to continue strong revenue growth in 2025 and beyond,” citing Yorvipath’s early U.S. momentum and SkyTROFA’s leadership in the domestic growth hormone market.&nbsp;Ascendis also confirmed plans to submit regulatory filings for TransCon CNP as a treatment for children with achondroplasia.The board also authorized up to $18.25 million for repurchases of its American depository receipt shares.&nbsp;On Stocktwits, message volume for Ascendis spiked, with several posts indicating optimism over the guidance and Yorvipath’s growth.<stembedurl>https://stocktwits.com/Pika_Capital/message/604018998</stembedurl><stembedurl>https://stocktwits.com/CrispDry/message/603879227</stembedurl>BofA Securities on Thursday lowered its price target on Ascendis shares to $192 from $203 while maintaining a ‘Buy’ rating.&nbsp;The firm adjusted its 2025 Yorvipath sales forecast downward, expecting a more backloaded ramp, but reiterated Ascendis as a “top pick for 2025” with projected peak sales of €2.9 billion.Yorvipath recently became the only approved U.S. treatment for hypoparathyroidism after Takeda discontinued Natpara production due to supply issues.Despite the day’s gains, Ascendis shares remain down over 10% in the past year and trade about 54% below the average analyst target of $193.49, according to Koyfin data.&nbsp;&nbsp;The company’s stock has a short interest of 5.4%.(1 Euro=$1.04)For updates and corrections, email newsroom[at]stocktwits[dot]com.

Ascendis Pharma Eyes Best Open In A Month After Q4 Print, But BofA Cuts Price Target: Retail Gets Buzzing

The brokerage adjusted its 2025 Yorvipath sales forecast downward, expecting a more backloaded ramp.

Equity

The brokerage adjusted its 2025 Yorvipath sales forecast downward, expecting a more backloaded ramp.


Ascendis Pharma A/S (NASDAQ:ASND) Given New $167.00 Price Target at JPMorgan Chase & Co.

Ascendis Pharma A/S (NASDAQ:ASND - Free Report) had its target price boosted by JPMorgan Chase & Co. from $165.00 to $167.00 in a research note issued to investors on Tuesday morning, Benzinga...

Ascendis Pharma A/S (NASDAQ:ASND) Given "Overweight" Rating at Cantor Fitzgerald

Cantor Fitzgerald reiterated their overweight rating on shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) in a report published on Monday morning, Benzinga reports. Cantor Fitzgerald...

Ascendis Pharma A/S (ASND, $151.98) Moving Average Convergence Divergence (MACD) Histogram turned positive on April 1, 2024

This is a Bullish indicator signaling ASND's price could rise from here. Traders may explore going long the stock or buying call options...

Ascendis Pharma A/S (ASND, $151.98) Stochastic Oscillator left the overbought zone on April 01, 2024

This is a signal that ASND's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...

Values First Advisors Inc. Lowers Position in Ascendis Pharma A/S (NASDAQ:ASND)

Values First Advisors Inc. reduced its stake in Ascendis Pharma A/S (NASDAQ:ASND  Free Report) by 23.4% in the fourth quarter, according to its most recent filing with the Securities and...

Ascendis Pharma A/S (ASND, $148.44) Stochastic Oscillator left the oversold zone on March 27, 2024

This is a signal that ASND's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...

1,616 Shares in Ascendis Pharma A/S (NASDAQ:ASND) Purchased by Legato Capital Management LLC

Legato Capital Management LLC purchased a new stake in Ascendis Pharma A/S (NASDAQ:ASND  Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities...

Ascendis Pharma A/S (NASDAQ:ASND) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of Ascendis Pharma A/S (NASDAQ:ASND  Get Free Report) have been assigned an average rating of Moderate Buy from the ten analysts that are covering the firm, MarketBeat...

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau on September 21, 2006 and is headquartered in Hellerup, Denmark.

Ascendis Pharma A/S - ADR

Just the one

Three

Four

The Fed just cut rates. How many cuts do you expect in all of 2025? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$0.32	--	--	N/A
Q2 '25	-$1.51	-$0.97	35.89%	BEAT
Q1 '25	-$1.67	-$1.84	-10.33%	MISSED
Q4 '24	-$0.98	-$0.72	25.80%	BEAT
Q3 '24	-$1.70	-$1.78	-4.65%	MISSED

ASND
Ascendis Pharma

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest ASND News

ASND Ascendis Pharma